Navigation Links
NIH study suggests that early detection is possible for prion diseases
Date:12/2/2010

duced conversion assay, or RT-QuIC. This approach is described in a paper now online in the open-access journal PLoS Pathogens. Byron Caughey, Ph.D., led the study at NIAID's Rocky Mountain Laboratories in Hamilton, Mont.

Scientists believe disease-causing prions are abnormal infectious clusters of prion protein molecules. Normally, prion protein molecules are unclustered, harmless and found in every mammal. In a process not fully understood, abnormal infectious clusters develop and can convert normal prion protein molecules into the infectious prion form; these clusters tend to gather in the brain. Ongoing replication allows the disease to spread and damage the brain.

Infectious prions also are found outside the brain, in saliva, blood, breast milk, urine and the nasal and cerebral spinal fluids used in the study. But the concentrations of infectious prions in these bodily fluids are so low that scientists, clinicians and wildlife biologists have not been able to measure them for routine purposes.

The new assay can detect when miniscule amounts of infectious prions initiate the conversion of large amounts of normal prion protein into an abnormal form in test-tube reactions. By comparing the extent to which different samples can be diluted and still initiate conversion, scientists can estimate the relative infectious concentrations in the original samples. In their study, the NIAID scientists used RT-QuIC to detect prion infections in deer known to have chronic wasting disease and sheep known to have scrapie. In scrapie-infected hamsters, they found surprisingly high levels of prions in nasal fluids, pointing to such fluids as possible sources of contagion in various prion diseases.

Along with optimizing their existing applications in the laboratory, Dr. Caughey and his colleagues are teaming up with a number of other laboratories around the world to extend the practical and scientific applications of RT-QuIC. Related testing a
'/>"/>

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Female Vets Much More Likely to Commit Suicide, Study Finds
2. Study Suggests Link Between Crohns Disease and PTSD
3. NIH study identifies ideal body mass index
4. MRSA carriage rates vary widely in nursing homes, study finds
5. CT Scans May Pose Less Cancer Risk Than Thought, Study Contends
6. Jefferson study determines bone marrow stromal stem cells may aid in stroke recovery
7. Sleepless soldiers: Study suggests that military deployment affects sleep patterns
8. Hospital-Acquired Infections a Serious Threat to ICU Patients: Study
9. Breast Cancer Rates Lower With Less Hormone Therapy: Study
10. Kids Cant Accurately Judge Speed of Approaching Cars: Study
11. Study Backs Active Surveillance for Low-Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... (PRWEB) December 25, 2014 Helen Harris’ ... in Woodland Hills, California after an 8 year battle ... on Christmas Eve evening in her home in Woodland ... metastatic breast cancer. , As the ... forty years, she pioneered and championed many of today's ...
(Date:12/25/2014)... LunaDress.co.uk has updated its blog to provide professional shopping tips on ... models at LunaDress.co.uk come with big discounts, up to 80 percent ... turn out to be a most exciting memory and can show ... surprise to a wedding. On the updated fashion blog, ladies can ... a big day . , Going out with friends to a ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... News) -- Among early stage breast cancer patients who ... one percent will eventually develop leukemia as a result ... finding comes from a review of more than 20,000 ... it suggests that the risk for developing treatment-related leukemia, ... thought. "The frequency of bone marrow cancers such ...
(Date:12/25/2014)... AngelWeddingDress.com tries its best to translate the experience ... business has introduced its new collection of 2015 prom ... The new prom outfits are guaranteed to contain the ... are specially designed for 2015. Anyone who wants to ... its website before Jan. 26, 2015, the deadline of ...
Breaking Medicine News(10 mins):Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
... networks , , FRIDAY, April 24 (HealthDay News) -- Better ... has led to steady improvements in the time needed ... heart attack, new research shows. , The study involved ... myocardial infarction (STEMI), the deadliest type of heart attack. ...
... researchers report , , FRIDAY, April 24 (HealthDay News) -- ... after heart bypass surgery are at increased long-term risk ... sounds a warning bell for doctors about an issue ... said Giovanni Filardo, director of the department of epidemiology ...
... advantage, study finds, , , FRIDAY, April 24 (HealthDay News) -- ... in better health than the general population, but for veterans ... , In fact, aging combat veterans have a poorer quality ... that was to be presented Friday at the American Heart ...
... New policy papers addressing comprehensive payment reform and ... released today by the American College of Physicians ... , Reforming Physician Payments to Achieve Greater ... Challenges Facing Primary Care Medicine: Comprehensive Strategies from ...
... Talecris Biotherapeutics, Inc. today announced the publication ... the largest clinical trial ever conducted in patients ... April 14, 2009 issue of Neurology . ... Gamunex (Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified) ...
... Drug Companies to Adopt "Smart" Drug Safety TechnologyARMONK, N.Y. ... -- IBM (NYSE: IBM ... Golden State Medical Supply (GSMS) today announced the two ... with stringent prescription drug pedigree regulations in advance of ...
Cached Medicine News:Health News:Coordination Has Led to Quicker Heart Treatment 2Health News:Abnormal Heartbeat After Bypass a Bad Sign 2Health News:Combat Duty Harms Long-Term Health of Vets 2Health News:Combat Duty Harms Long-Term Health of Vets 3Health News:Payment reform and solutions to challenges facing primary care addressed in policy papers 2Health News:Payment reform and solutions to challenges facing primary care addressed in policy papers 3Health News:Landmark study demonstrates Gamunex improves health-related quality of life in patients with CIDP 2Health News:Landmark study demonstrates Gamunex improves health-related quality of life in patients with CIDP 3Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 2Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 3
(Date:12/24/2014)... N.C. , Dec. 23, 2014  Endo Pharmaceuticals ... ENDP ) (TSX: ENL), and BioDelivery Sciences International, ... they have submitted a New Drug Application (NDA) for ... Drug Administration (FDA).  Buprenorphine HCl Buccal Film is under ... require daily, around-the-clock, long-term opioid treatment and for which ...
(Date:12/22/2014)... and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ) has announced ... Market" report to their offering. ... focuses on the developments in the self-monitoring blood glucose ... Reimbursement analysis and the effects of competitive bidding have ... SMBG meters have been performed, based on the various ...
(Date:12/22/2014)... and STOCKHOLM , Dec. 22, ... and partner Auxilium Pharmaceuticals, Inc. today announced that the ... the European Medicines Agency (EMA) has adopted a positive ... for the treatment of adult men with Peyronie,s disease ... least 30 degrees at the start of therapy. ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... Therapeutics, Inc. (Nasdaq: NLTX ), a company focused ... disease, today announced its third quarter financial results for 2010. ... 30, 2010, Nile reported a net loss of approximately $1.8 ... of approximately $2.0 million, or $0.08 per share, during the ...
... N.J., Nov. 12, 2010 Neurologix, Inc. (OTC Bulletin ... company developing innovative gene therapies for the brain and ... for the three and nine months ended September 30, ... potential of NLX-P101, our Parkinson,s disease gene therapy product, ...
Cached Medicine Technology:Nile Therapeutics Reports 2010 Third Quarter Financial Results 2Nile Therapeutics Reports 2010 Third Quarter Financial Results 3Nile Therapeutics Reports 2010 Third Quarter Financial Results 4Neurologix Reports Third Quarter 2010 Financial Results 2Neurologix Reports Third Quarter 2010 Financial Results 3Neurologix Reports Third Quarter 2010 Financial Results 4Neurologix Reports Third Quarter 2010 Financial Results 5Neurologix Reports Third Quarter 2010 Financial Results 6Neurologix Reports Third Quarter 2010 Financial Results 7Neurologix Reports Third Quarter 2010 Financial Results 8
Auto refractometer....
A system with integrated pupil camera and 7" examination monitor. An easy to use configuration....
... The Selecta II Glaucoma Laser System features ... patients with open-angle glaucoma. It selectively targets ... intraocular pressure. The Selecta II is equipped ... high-energy beam of light, which induces the ...
Round handle....
Medicine Products: